Pharma – Kinevant

Evaluation of an Anti-GM-CSF Monoclonal Antibody (Namilumab) in a Phase 2 Pulmonary Sarcoidosis Trial, Robert Baughman (USA), Kiyomi Komori (USA)

Chairs: Irina Strâmbu (Romania)